IMWG Consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for myeloma and the role of plerixafor

This article, written by an expert panel on behalf of the International Myeloma Working Group, discusses a variety of issues regarding stem cell collection and transplantation in myeloma and the role of plerixafor, providing a summary of the deliberations and conclusions.

BCSH/BSBMT Guidelines for organ-specific management and supportive care in chronic graft-versus-host disease

This paper, written by a joint working group established by the Haemato-oncology subgroup of the British Committee for Standards in Haematology and the British Society for Bone Marrow Transplantation, reviews the available literature and made recommendations for the supportive care and management of organ-specific complications of chronic graft-versus-host disease (cGvHD).

BCSH/BSBMT Guidelines for the diagnosis and management of chronic graft-versus-host disease

This guideline, produced by a joint working group established by the Haemato-Oncology subgroup of the British Committee for Standards in Haematology (BCSH) and the British Society for Bone Marrow Transplantation (BSBMT) reviews the available literature and makes recommendations for the diagnosis and management of chronic graft-versus-host disease (GvHD).

BCSH/BSBMT Guidelines for the diagnosis and management of acute graft-versus-host disease

This guideline, written by a joint working group established by the Haemato-oncology subgroup of the British Committee for Standards in Haematology (BCSH) and the British Society for Bone Marrow Transplantation (BSBMT), reviews the available literature and makes recommendations for the diagnosis and management of acute graft-versus-host disease.

Tutorials

Good communication and sensitive delivery of information to patients and families is critical at all stages of a myeloma diagnosis and treatment. These tutorials demonstrate a number of different clinical scenarios and convey the patient experience in the HCP setting. The objective is to demonstrate best practice to help you improve the patient experience during…

Related conditions

Treatment recommendations for patients with Waldenström’s Macroglobulinemia (WM) and related disorders: consensus from the Seventh International Workshop on WM. Dimopoulos M et al. Blood. 2014 Jul 15. pii: blood-2014-03-565135. [Epub ahead of print]. Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myeloma. Weinhold N et al. Leukemia. 2014 Jul 3. doi: 10.1038/leu.2014.208. [Epub ahead of…

General

European Perspective on Multiple Myeloma Treatment Strategies in 2014. Ludwig H et al. Oncologist. 2014 Jul 25. pii: theoncologist.2014-0042. [Epub ahead of print]. The roles of consolidation and maintenance therapy with novel agents after autologous stem cell transplantation in patients with multiple myeloma. Joks M et al. Eur J Haematol. 2014 Jul 10. doi: 10.1111/ejh.12412.…